 blood cell trafficking for treatment of inflammatory diseases. This project aims at determining if the administration of Betaseron affects the progression of secondary-progressive multiple sclerosis. Bone metastasis occurs in 49% of patients with cancer of the breast. Although the diagnosis is currently made by x-rays and scintiscanning, there are no
blood cell trafficking for treatment of inflammatory disease. This undertaking target at determining if the administration of Betaseron affect the progression of secondary - progressive multiple sclerosis. Bone metastasis happen in 49% of patients with cancer of the breast. Although the diagnosis is currently make by x - rays and scintiscanning, there be no
 bllod cell trafficking for treatment of iudlammavory diaeases. Tfis project aims at determinmng uf tht administration of Betaseroj affectw tht progression of secondarn-'rogrsdsivz nultiple sclerpsis. Bone ketastasis occgrr nn 49% of patients with cancer of the bweast. Aktjough the diaggosix is dlrvently made by x-rays and scintisdanning, there are no
blood cell trafficking for treatment of inflammatory project at determining the administration of secondary-progressive sclerosis. Bone metastasis in 49% of with cancer of the breast. Although diagnosis is currently made by x-rays and scintiscanning, there are no
 blood cell trafficking for trEatment of iNflamMatOry DiSeasEs. ThIs project aims aT DeteRmining if the administraTion oF BETaseROn AffecTs the prOGrESSioN oF sEcoNdARy-ProgrEssIve multIple scleroSis. boNe metastasis OCcUrs in 49% of patIenTs with cancer Of tHe breaSt. altHOugh tHe dIagnoSis is cURrentlY made by x-rAyS And sciNTiscannING, tHere Are no
 blood cell trafficking fo r treatmen t ofinf lam ma tory  dis eases. This pr o ject  aims at determining i f the  a d mini s tr ation  of Bet a se r o n a ff ec tsth e  p rogre ssi on of s econdary-p rog re ssive multip l esclerosis.  Bo ne metastasi s o ccursin  49 %  of p ati entswith c a ncer o f the bre as t . Alth o ugh the d ia gnos is is currently m a de by x-rays andscinti sc a nn i n g,the re are no
 blood_cell trafficking_for treatment of inflammatory_diseases. This_project_aims at_determining_if the administration_of Betaseron affects_the progression of secondary-progressive_multiple sclerosis. Bone_metastasis_occurs in 49% of patients with cancer of the breast. Although the diagnosis is_currently_made by_x-rays_and_scintiscanning, there are no